Pharmafile Logo

Peter Impey

UCB CEO elected to the Ministerial Industry Strategy Group

Jean-Christophe Tellier assumed the role of CEO on January 1

- PMLiVE

UK doctors call on NHS to use Avastin for wet AMD

Controversial practice of using the drug off-label could save the health service £102m

E-detailing content wow factor in 2015

Many companies are reporting that the iPad novelty has worn off and healthcare professionals are demanding more than just another animation presented on a mobile device. So what exactly are...

Anthill Agency

Start me up: A balancing act

The fun, the necessary and other tales from a new creative agency's frontline

- PMLiVE

Novartis gets OK for panobinostat in myeloma

First HDAC to receive positive FDA review

Eli Lilly HQ

Lilly delays filing of Lantus rival on safety concerns

Concerns over changes in liver fat detected in phase III trials

- PMLiVE

Google-backed genetic testing kit gains FDA approval

23andMe’s DNA test can alert consumers to their risks of certain diseases

- PMLiVE

Google-backed genetic testing kit gains FDA approval

23andMe’s DNA test can alert consumers to their risks of certain diseases

France flag

French pharma growth restricted by generics

New analysis finds country’s market value will grow only modestly in the coming years

- PMLiVE

Novo Nordisk’s oral GLP-1 analogue looks set for phase III

Semaglutide said to be one of the firm’s most promising prospects

- PMLiVE

Valeant swoops on Salix with $10bn takeover deal

Firm will also absorb Salix’s $4.6bn debt, adding to its existing $15bn

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links